Insperity (NSP) stock has come under pressure after reports of slowing demand, revenue growth running below its historical trend, declining earnings per share, and a weakening free cash flow margin raised fresh questions around profitability.

Despite the recent concerns around Insperity’s fundamentals, the share price has rallied strongly with a 30 day share price return of 23% and an 81.82% 90 day share price return, although the 1 year total shareholder return is still down 16.18%. This points to improving short term momentum alongside a weaker longer term record.

If this kind of sharp rebound has your attention, it can help to compare Insperity with other companies showing clearer long term trends via the 18 top founder-led companies

So after a sharp short term rebound in Insperity despite softer fundamentals, are buyers still being paid enough for the business risks at today’s price, or has the recent move already used up most of the upside?

Most Popular Narrative: 12.4% Overvalued

Compared with Insperity’s last close at $45.51, the most widely followed narrative anchors fair value at $40.50, framing current pricing as ahead of those assumptions.

The upcoming launch of Insperity HRScale, a joint solution with Workday, targets a broader and more lucrative mid-market segment, leveraging both advanced HR technology and comprehensive services. This is expected to drive higher revenue growth and improved operating leverage as premium pricing and larger average client size become possible.

Want to see what sits behind that fair value gap for Insperity? The narrative leans heavily on revenue compounding, margin repair and a richer future earnings multiple. The exact mix of growth, profitability and discounting tells a very specific story that the current share price only partly reflects.

Result: Fair Value of $40.50 (OVERVALUED)

However, Insperity’s reliance on smaller business clients and exposure to healthcare and benefits cost inflation could quickly challenge the current earnings recovery story.

Another View: Insperity’s Value Through a Different Lens

The narrative model suggests Insperity is 12.4% overvalued at $45.51 versus a $40.50 fair value anchor, yet our DCF model points in the opposite direction, indicating the stock trades around 79.5% below its future cash flow value at $221.94. When two methods disagree this sharply, which one do you trust more for your own thesis?

Next Steps

If the mixed messages around Insperity leave you unsure, this is the moment to look through the data yourself and move quickly to form a clear stance using our breakdown of 3 key rewards and 1 important warning sign

Looking for more investment ideas beyond Insperity?

If Insperity has sharpened your focus, do not stop there. Use data driven stock ideas to broaden your watchlist and uncover opportunities you might otherwise overlook.

• Target resilient opportunities by scanning companies with 76 resilient stocks with low risk scores that may better match your appetite for steadier return profiles and controlled downside.
• Hunt for quality at a sensible price by reviewing 44 high quality undervalued stocks that combine solid fundamentals with pricing that some investors may have overlooked.
• Spot earlier stage prospects by checking 20 elite penny stocks with strong financials where stronger financials set them apart from many other low priced stocks on the market.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.